Aethlon Medical
AEMD
7 hedge funds and large institutions have $2.26M invested in Aethlon Medical in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
2% less capital invested
Capital invested by funds: $2.3M → $2.26M (-$38K)
Top Buyers
| 1 |
Northern Trust
Chicago,
Illinois
|
+$70K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$70K |
Top Sellers
| 1 |
Lido Advisors
Los Angeles,
California
|
-$73K |
AEMD Hedge Fund Activity: Q3 2016 in Review
7 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2016, worth a combined $2.26M — down 1.7% from $2.3M a quarter earlier.
Fund positioning in AEMD was balanced in Q3 2016: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Northern Trust, opening a new position worth an estimated $70K. The largest seller was Lido Advisors, exiting entirely with an estimated $73K sold.
- 7 institutional investors held Aethlon Medical (AEMD) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $2.26M of Aethlon Medical stock for Q3 2016, down 1.7% quarter-over-quarter.
- 1 fund opened new Aethlon Medical positions in Q3 2016 and 1 closed out, a net change of 0 holders.
- The largest Aethlon Medical buyer in Q3 2016 was Northern Trust, an estimated $70K added.
- The largest Aethlon Medical seller in Q3 2016 was Lido Advisors, an estimated $73K sold.
Based on aggregated 13F filings for Q3 2016.